Loading…

The SPRINT study: Outcome may be driven by difference in diuretic treatment demasking heart failure and study design may support systolic blood pressure target below 140 mmHg rather than below 120 mmHg

Saved in:
Bibliographic Details
Published in:Blood pressure 2016-03, Vol.25 (2), p.63-66
Main Authors: Kjeldsen, Sverre E., Narkiewicz, Krzysztof, Hedner, Thomas, Mancia, Giuseppe
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c483t-80de3cef77a3ee03ee9460069119f831ed3412a7e98047563a75172c5de674743
cites cdi_FETCH-LOGICAL-c483t-80de3cef77a3ee03ee9460069119f831ed3412a7e98047563a75172c5de674743
container_end_page 66
container_issue 2
container_start_page 63
container_title Blood pressure
container_volume 25
creator Kjeldsen, Sverre E.
Narkiewicz, Krzysztof
Hedner, Thomas
Mancia, Giuseppe
description
doi_str_mv 10.3109/08037051.2015.1130775
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_26743157</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1765108672</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-80de3cef77a3ee03ee9460069119f831ed3412a7e98047563a75172c5de674743</originalsourceid><addsrcrecordid>eNp9kcFu1DAQhi0EotvCI4B85JJlHCdxwglUQVupogiWc-SNJ7uG2A62Q5UbVx6Ol-BJcNhdjhwsy5pv_rHmI-QZgzVn0LyEGriAkq1zYOWaMQ5ClA_IilUly1jTNA_JamGyBToj5yF8AWCcAzwmZ3klCs5KsSK_Nnuknz58vHm_oSFOan5F76bYOYPUyJlukSqvv6Ol25kq3ffo0XZItU2vyWPUHY0eZTRoI1VoZPiq7Y7uUfpIe6mHBFFp1SE8EUHv7N_oMI2jS1CYQ3RDytkOzik6egxhaYrS7zCmHwzunrICfv_4acz1jnoZ9-hp3Et7Kuan4hPyqJdDwKfH-4J8fvd2c3md3d5d3Vy-uc26ouYxq0Eh77AXQnJESKcpKoCqYazpa85Q8YLlUmBTQyHKiktRMpF3pcK0uLS6C_LikDt6923CEFujQ4fDIC26KbRMJAtQVyJPaHlAO-9C8Ni3o9dG-rll0C4m25PJdjHZHk2mvufHEdPWoPrXdVKXgNcHQNveeSPvnR9UG-U8ON97aTsdlvz_zfgDWZyxQQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1765108672</pqid></control><display><type>article</type><title>The SPRINT study: Outcome may be driven by difference in diuretic treatment demasking heart failure and study design may support systolic blood pressure target below 140 mmHg rather than below 120 mmHg</title><source>EZB Electronic Journals Library</source><creator>Kjeldsen, Sverre E. ; Narkiewicz, Krzysztof ; Hedner, Thomas ; Mancia, Giuseppe</creator><creatorcontrib>Kjeldsen, Sverre E. ; Narkiewicz, Krzysztof ; Hedner, Thomas ; Mancia, Giuseppe</creatorcontrib><identifier>ISSN: 0803-7051</identifier><identifier>EISSN: 1651-1999</identifier><identifier>DOI: 10.3109/08037051.2015.1130775</identifier><identifier>PMID: 26743157</identifier><language>eng</language><publisher>England: Taylor &amp; Francis</publisher><subject>Antihypertensive Agents - therapeutic use ; Female ; Humans ; Hypertension - drug therapy ; Male ; Patient Care Planning</subject><ispartof>Blood pressure, 2016-03, Vol.25 (2), p.63-66</ispartof><rights>2016 Scandinavian Foundation for Cardiovascular Research 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-80de3cef77a3ee03ee9460069119f831ed3412a7e98047563a75172c5de674743</citedby><cites>FETCH-LOGICAL-c483t-80de3cef77a3ee03ee9460069119f831ed3412a7e98047563a75172c5de674743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26743157$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kjeldsen, Sverre E.</creatorcontrib><creatorcontrib>Narkiewicz, Krzysztof</creatorcontrib><creatorcontrib>Hedner, Thomas</creatorcontrib><creatorcontrib>Mancia, Giuseppe</creatorcontrib><title>The SPRINT study: Outcome may be driven by difference in diuretic treatment demasking heart failure and study design may support systolic blood pressure target below 140 mmHg rather than below 120 mmHg</title><title>Blood pressure</title><addtitle>Blood Press</addtitle><subject>Antihypertensive Agents - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension - drug therapy</subject><subject>Male</subject><subject>Patient Care Planning</subject><issn>0803-7051</issn><issn>1651-1999</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kcFu1DAQhi0EotvCI4B85JJlHCdxwglUQVupogiWc-SNJ7uG2A62Q5UbVx6Ol-BJcNhdjhwsy5pv_rHmI-QZgzVn0LyEGriAkq1zYOWaMQ5ClA_IilUly1jTNA_JamGyBToj5yF8AWCcAzwmZ3klCs5KsSK_Nnuknz58vHm_oSFOan5F76bYOYPUyJlukSqvv6Ol25kq3ffo0XZItU2vyWPUHY0eZTRoI1VoZPiq7Y7uUfpIe6mHBFFp1SE8EUHv7N_oMI2jS1CYQ3RDytkOzik6egxhaYrS7zCmHwzunrICfv_4acz1jnoZ9-hp3Et7Kuan4hPyqJdDwKfH-4J8fvd2c3md3d5d3Vy-uc26ouYxq0Eh77AXQnJESKcpKoCqYazpa85Q8YLlUmBTQyHKiktRMpF3pcK0uLS6C_LikDt6923CEFujQ4fDIC26KbRMJAtQVyJPaHlAO-9C8Ni3o9dG-rll0C4m25PJdjHZHk2mvufHEdPWoPrXdVKXgNcHQNveeSPvnR9UG-U8ON97aTsdlvz_zfgDWZyxQQ</recordid><startdate>20160303</startdate><enddate>20160303</enddate><creator>Kjeldsen, Sverre E.</creator><creator>Narkiewicz, Krzysztof</creator><creator>Hedner, Thomas</creator><creator>Mancia, Giuseppe</creator><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160303</creationdate><title>The SPRINT study: Outcome may be driven by difference in diuretic treatment demasking heart failure and study design may support systolic blood pressure target below 140 mmHg rather than below 120 mmHg</title><author>Kjeldsen, Sverre E. ; Narkiewicz, Krzysztof ; Hedner, Thomas ; Mancia, Giuseppe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-80de3cef77a3ee03ee9460069119f831ed3412a7e98047563a75172c5de674743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Antihypertensive Agents - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension - drug therapy</topic><topic>Male</topic><topic>Patient Care Planning</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kjeldsen, Sverre E.</creatorcontrib><creatorcontrib>Narkiewicz, Krzysztof</creatorcontrib><creatorcontrib>Hedner, Thomas</creatorcontrib><creatorcontrib>Mancia, Giuseppe</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Blood pressure</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kjeldsen, Sverre E.</au><au>Narkiewicz, Krzysztof</au><au>Hedner, Thomas</au><au>Mancia, Giuseppe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The SPRINT study: Outcome may be driven by difference in diuretic treatment demasking heart failure and study design may support systolic blood pressure target below 140 mmHg rather than below 120 mmHg</atitle><jtitle>Blood pressure</jtitle><addtitle>Blood Press</addtitle><date>2016-03-03</date><risdate>2016</risdate><volume>25</volume><issue>2</issue><spage>63</spage><epage>66</epage><pages>63-66</pages><issn>0803-7051</issn><eissn>1651-1999</eissn><cop>England</cop><pub>Taylor &amp; Francis</pub><pmid>26743157</pmid><doi>10.3109/08037051.2015.1130775</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0803-7051
ispartof Blood pressure, 2016-03, Vol.25 (2), p.63-66
issn 0803-7051
1651-1999
language eng
recordid cdi_pubmed_primary_26743157
source EZB Electronic Journals Library
subjects Antihypertensive Agents - therapeutic use
Female
Humans
Hypertension - drug therapy
Male
Patient Care Planning
title The SPRINT study: Outcome may be driven by difference in diuretic treatment demasking heart failure and study design may support systolic blood pressure target below 140 mmHg rather than below 120 mmHg
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T16%3A02%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20SPRINT%20study:%20Outcome%20may%20be%20driven%20by%20difference%20in%20diuretic%20treatment%20demasking%20heart%20failure%20and%20study%20design%20may%20support%20systolic%20blood%20pressure%20target%20below%20140%E2%80%89mmHg%20rather%20than%20below%20120%E2%80%89mmHg&rft.jtitle=Blood%20pressure&rft.au=Kjeldsen,%20Sverre%20E.&rft.date=2016-03-03&rft.volume=25&rft.issue=2&rft.spage=63&rft.epage=66&rft.pages=63-66&rft.issn=0803-7051&rft.eissn=1651-1999&rft_id=info:doi/10.3109/08037051.2015.1130775&rft_dat=%3Cproquest_pubme%3E1765108672%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c483t-80de3cef77a3ee03ee9460069119f831ed3412a7e98047563a75172c5de674743%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1765108672&rft_id=info:pmid/26743157&rfr_iscdi=true